Form 4 for ACHC Acadia Healthcare Company, Inc.
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-27 · accession 0000950170-25-030196 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-28 | 2025-02-27 | ACHC | HUNTER CHRISTOPHER H. | CEO, Dir | A - Grant | $0.00 | +19.8K | 136.6K | +17% | $0 |
| 2025-02-28 | 2025-02-27 | ACHC | HUNTER CHRISTOPHER H. | CEO, Dir | F - Tax | $40.26 | -17.0K | 132.8K | -11% | -$684.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-27 | A | A | 13,124 | $0.00 | 149,756 | D | — | — | (F2) Shares earned based on 2024 performance under performance vesting restricted stock units awarded on May 9, 2023. The shares will not be issued until the end of the three-year period under the restricted stock unit award. |
| 2 | Common | Common Stock | 2025-02-27 | A | A | 6,672 | $0.00 | 136,632 | D | — | — | (F1) Shares received upon vesting of performance vesting restricted stock units awarded on April 11, 2022. |
| 3 | Common | Common Stock | 2025-02-27 | F | D | 16,995 | $40.26 | 132,761 | D | — | — |